Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10549-011-1713-xPMID 21850397PMCID PMC4523065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.

  2010cited by this paper
• Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

  2010cited by this paper
• Dasatinib induces autophagic cell death in human ovarian cancer

  2010cited by this paper
• Emerging targeted therapies for breast cancer.

  2010cited by this paper
• Autophagy in cellular growth control

  2010cited by this paper
• Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro.

  2010cited by this paper
• Phase I study of intermittent dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF- 1R) and insulin receptor (IR) in patients with advanced solid tumors.

  2010cited by this paper
• Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

  2010cited by this paper
• Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved

  2010cited by this paper
• Inaugural Article: Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

  2010cited by this paper
• The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models

  2010cited by this paper
• Inhibition of Cancer Cell Proliferation and Metastasis by Insulin Receptor Downregulation

  2010cited by this paper
• Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

  2009cited by this paper
• Sequencing of Type I Insulin-Like Growth Factor Receptor Inhibition Affects Chemotherapy Response In vitro and In vivo

  2009influential reference
• Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells.

  2009cited by this paper
• Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor.

  2009cited by this paper
• Differential Roles of Insulin-like Growth Factor Receptor – and Insulin Receptor – mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells 1 , 2

  2009cited by this paper
• Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

  2009cited by this paper
• ARF, autophagy and tumor suppression

  2009cited by this paper
• ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery.

  2009cited by this paper
• MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?

  2009cited by this paper
• Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.

  2009cited by this paper
• The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival

  2009cited by this paper
• Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.

  2009cited by this paper
• Insulin and insulin-like growth factor signalling in neoplasia

  2008cited by this paper
• Autophagy in the pathogenesis of disease.

  2008cited by this paper
• Regulation of Breast Cancer Metastasis by IGF Signaling

  2008cited by this paper
• IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons

  2008cited by this paper
• Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

  2008cited by this paper
• Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.

  2008cited by this paper
• MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research

  2007cited by this paper
• Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

  2007cited by this paper
• Emerging targeted therapies for breast cancer.

  2007cited by this paper
• A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo

  2007influential reference
• How to Interpret LC3 Immunoblotting

  2007cited by this paper
• Targeted therapy: wave of the future.

  2005cited by this paper
• Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells

  2005cited by this paper
• Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.

  2005cited by this paper
• A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells*

  2004cited by this paper
• The IGF system and breast cancer.

  2001cited by this paper
• Linear Mixed Models for Longitudinal Data

  2001cited by this paper
• Structure and function of the insulin-like growth factor I receptor

  1998cited by this paper
• Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting.

  1997cited by this paper
• MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

  1996cited by this paper
• Mechanism of action of topoisomerase II-targeted antineoplastic drugs.

  1994cited by this paper
• Insulin-like growth factor receptor expression and function in human breast cancer.

  1990cited by this paper

• Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells

  2025cites this paper
• Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer

  2024cites this paper
• Targeted biocompatible Zn-metal–organic framework nanocomposites for intelligent chemotherapy of breast cancer cells

  2024cites this paper
• Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors

  2023cites this paper
• Pharmacological activity and mechanism of pyrazines.

  2023cites this paper
• The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides

  2022cites this paper
• Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer

  2021cites this paper
• Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma

  2020cites this paper
• Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

  2020cites this paper
• Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.

  2018cites this paper
• An Open‐Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC‐A12) as a First‐Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

  2017cites this paper
• Inhibiting IGF-1R attenuates cell proliferation and VEGF production in IGF-1R over-expressing EGFR mutant non-small cell lung cancer cells

  2017cites this paper
• Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.

  2017cites this paper
• A comprehensive pharmacokinetic/pharmacodynamics analysis of the novel IGF1R/INSR inhibitor BI 893923 applying in vitro, in vivo and in silico modeling techniques

  2016cites this paper
• IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide

  2015cites this paper
• The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link

  2015cites this paper
• A Tale of Two Receptors: Insulin and Insulin-Like Growth Factor Signaling in Cancer

  2014cites this paper
• Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.

  2014cites this paper
• Lipid Signaling in Tumorigenesis.

  2014cites this paper
• Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice.

  2014cites this paper
• Can we unlock the potential of IGF-1R inhibition in cancer therapy?

  2014cites this paper
• Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer

  2014cites this paper
• A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): Implications for Inhibition of the IGF-1R signal

  2013cites this paper
• Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors.

  2013cites this paper
• Targeting the insulin-like growth factor-1 receptor in human cancer

  2013cites this paper
• The Links Between Insulin Resistance, Diabetes, and Cancer

  2013cites this paper
• Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer

  2013cites this paper
• In Vivo Anti-Tumor Activity of a New Doxorubicin Conjugate via α-Linolenic Acid

  2012cites this paper
• Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks.

  2012cites this paper
• Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer

  2012cites this paper
• Insulin-like growth factor receptor inhibitors: baby or the bathwater?

  2012cites this paper
• Anti-tumor Activity of IGF-1R Kinase Inhibitor PQIP in Colon Cancer

  2011cites this paper
• Down-regulation of miRNA-452 is Associated with Adriamycin-resistance in Breast Cancer Cells

  year unknowncites this paper